HK1013983A1 - Synthetic excitatory amino acids - Google Patents

Synthetic excitatory amino acids

Info

Publication number
HK1013983A1
HK1013983A1 HK98115178A HK98115178A HK1013983A1 HK 1013983 A1 HK1013983 A1 HK 1013983A1 HK 98115178 A HK98115178 A HK 98115178A HK 98115178 A HK98115178 A HK 98115178A HK 1013983 A1 HK1013983 A1 HK 1013983A1
Authority
HK
Hong Kong
Prior art keywords
amino acids
excitatory amino
synthetic excitatory
synthetic
acids
Prior art date
Application number
HK98115178A
Other languages
English (en)
Inventor
David R Helton
James Allen Monn
Darryle D Schoepp
Joseph P Tizzano
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/496,643 external-priority patent/US5750566A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1013983A1 publication Critical patent/HK1013983A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/38—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98115178A 1994-08-12 1998-12-23 Synthetic excitatory amino acids HK1013983A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28995794A 1994-08-12 1994-08-12
US33734994A 1994-11-10 1994-11-10
US08/496,643 US5750566A (en) 1994-08-12 1995-06-29 Synthetic excitatory amino acids

Publications (1)

Publication Number Publication Date
HK1013983A1 true HK1013983A1 (en) 1999-09-17

Family

ID=27403949

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115178A HK1013983A1 (en) 1994-08-12 1998-12-23 Synthetic excitatory amino acids

Country Status (25)

Country Link
US (2) US5925782A (da)
EP (1) EP0696577B1 (da)
JP (1) JP2883297B2 (da)
CN (1) CN1066135C (da)
AP (1) AP758A (da)
AT (1) ATE172186T1 (da)
AU (2) AU692276B2 (da)
BG (1) BG62728B1 (da)
CA (1) CA2156024C (da)
CZ (1) CZ291270B6 (da)
DE (1) DE69505318T2 (da)
DK (1) DK0696577T3 (da)
ES (1) ES2122456T3 (da)
FI (1) FI114861B (da)
HK (1) HK1013983A1 (da)
HU (1) HU223845B1 (da)
IL (2) IL114910A (da)
MY (1) MY115977A (da)
NO (1) NO306342B1 (da)
NZ (1) NZ272772A (da)
PL (1) PL182285B1 (da)
RO (1) RO119147B1 (da)
SK (1) SK281288B6 (da)
TW (1) TW438741B (da)
WO (1) WO1996005175A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118727A (en) * 1995-06-29 2003-01-12 Lilly Co Eli (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5688826A (en) * 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
ZA969485B (en) * 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
WO1997017950A1 (en) 1995-11-16 1997-05-22 Eli Lilly And Company Shoulder prosthesis
US5912248A (en) * 1995-11-16 1999-06-15 Eli Lilly And Company Excitatory amino acid receptor antagonists
NZ323205A (en) * 1995-11-16 1999-06-29 Lilly Co Eli Excitatory amino acid derivatives
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
JP2001511131A (ja) * 1997-01-29 2001-08-07 イーライ・リリー・アンド・カンパニー 月経前不快障害の処置
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
ATE214704T1 (de) * 1997-07-18 2002-04-15 Hoffmann La Roche 5h-thiazolo(3,2-a)pyrimidinderivate
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
US6204292B1 (en) 1997-07-18 2001-03-20 Georgetown University Bicyclic metabotropic glutamate receptor ligands
JP3727791B2 (ja) * 1998-01-08 2005-12-14 ファイザー・プロダクツ・インク 二環式［３．１．０］ヘキサン及び関連化合物
ES2191412T3 (es) 1998-01-28 2003-09-01 Taisho Pharmaceutical Co Ltd Derivados de aminoacidos que contienen fluor.
US5933378A (en) * 1998-02-26 1999-08-03 Micron Technology, Inc. Integrated circuit having forced substrate test mode with improved substrate isolation
SI1064256T1 (en) * 1998-03-17 2004-10-31 Pfizer Products Inc. Bicyclo (2.2.1) heptanes and related compounds
NZ506227A (en) * 1998-03-17 2003-06-30 Pfizer Prod Inc Bicyclo[2.2.1]heptanes and their use in treating neurological and psychiatric disorders
GB9815542D0 (en) * 1998-07-17 1998-09-16 Lilly Co Eli Bicyclohexane derivatives
CN1247527C (zh) 1998-08-31 2006-03-29 大正制药株式会社 6－氟双环[3.1.0]己烷衍生物
CH694053A5 (de) * 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
JP4192331B2 (ja) 1999-04-16 2008-12-10 住友化学株式会社 光学活性２−オキソビシクロ［３．１．０］ヘキサン−６−カルボン酸誘導体の製造方法
JP4783967B2 (ja) * 1999-07-21 2011-09-28 大正製薬株式会社 含フッ素アミノ酸誘導体を有効成分とする医薬
GB2355982A (en) * 1999-11-03 2001-05-09 Lilly Co Eli Heterocyclic amino acids
EP1310480A1 (en) * 2001-11-07 2003-05-14 Eli Lilly & Company Prodrugs of excitatory amino acids
WO2002055485A1 (en) 2001-01-11 2002-07-18 Eli Lilly And Company Prodrugs of excitatory amino acids
HUP0400620A3 (en) * 2001-01-11 2012-09-28 Lilly Co Eli Prodrugs of excitatory amino acids and pharmaceutical compositions containing them and process for preparation the compounds
AU2002353845A1 (en) * 2001-11-23 2003-06-10 Eli Lilly And Company Prodrugs of excitatory amino acids
US7456221B2 (en) 2001-12-21 2008-11-25 Eli Lilly And Company Prodrugs of excitatory amino acids
AU2002361611A1 (en) * 2001-12-21 2003-07-24 Eli Lilly And Company Prodrugs of excitatory amino acids
US20040116489A1 (en) * 2002-02-12 2004-06-17 Massey Steven Marc Synthetic excitatory amino acids
JP4964593B2 (ja) * 2003-09-25 2012-07-04 セノメド バイオサイエンシーズ，エルエルシー 神経学的病状の治療用のテトラヒドロインドロン誘導体
US20050107439A1 (en) * 2003-11-10 2005-05-19 Helton David R. Composition and method for treating emesis
WO2009062134A1 (en) * 2007-11-09 2009-05-14 Cenomed Biosciences, Llc Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
US20090264443A1 (en) * 2008-04-18 2009-10-22 David Helton Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3704312A (en) * 1970-10-30 1972-11-28 American Home Prod Bialicyclic amino acids
US3746495A (en) * 1971-06-01 1973-07-17 American Home Prod Anti-ulcer therapy
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids

Also Published As

Publication number Publication date
CZ207495A3 (en) 1996-05-15
SK281288B6 (sk) 2001-02-12
JP2883297B2 (ja) 1999-04-19
CZ291270B6 (cs) 2003-01-15
HU9502380D0 (en) 1996-05-28
CA2156024C (en) 2004-10-05
BG101213A (en) 1998-03-31
DK0696577T3 (da) 1999-06-23
IL133493A0 (en) 2001-04-30
AU3325195A (en) 1996-03-07
WO1996005175A1 (en) 1996-02-22
IL114910A0 (en) 1995-12-08
IL114910A (en) 2000-06-29
NO953191L (no) 1996-02-13
JPH08188561A (ja) 1996-07-23
NO953191D0 (no) 1995-08-14
CN1123272A (zh) 1996-05-29
HU223845B1 (hu) 2005-02-28
HUT75524A (en) 1997-05-28
PL182285B1 (pl) 2001-12-31
EP0696577A1 (en) 1996-02-14
AP758A (en) 1999-09-10
CN1066135C (zh) 2001-05-23
FI953837A (fi) 1996-02-13
AU2853095A (en) 1996-02-22
US5925782A (en) 1999-07-20
TW438741B (en) 2001-06-07
MY115977A (en) 2003-10-31
ATE172186T1 (de) 1998-10-15
RO119147B1 (ro) 2004-04-30
DE69505318T2 (de) 1999-03-25
AU692276B2 (en) 1998-06-04
ES2122456T3 (es) 1998-12-16
EP0696577B1 (en) 1998-10-14
DE69505318D1 (de) 1998-11-19
FI953837A0 (fi) 1995-08-14
AP9700922A0 (en) 1997-01-31
SK13397A3 (en) 1997-07-09
NZ272772A (en) 1997-10-24
PL309972A1 (en) 1996-02-19
CA2156024A1 (en) 1996-02-13
FI114861B (fi) 2005-01-14
NO306342B1 (no) 1999-10-25
US5925680A (en) 1999-07-20
BG62728B1 (bg) 2000-06-30

Similar Documents

Publication Publication Date Title
AP9700922A0 (en) Synthetic excitatory amino acids
SI0964856T1 (en) Bicyclic amino acids
EP0801644A4 (en) POLYARYLCARBAMOYLAZADIOQUE ACIDS AND CARBAMOYLALCANEDIO QUES
NZ323205A (en) Excitatory amino acid derivatives
GB9510830D0 (en) Proteins
ZA952008B (en) 5-vinyl- and 5-ethinyl-quinolene- and -naphthyridone- carboxylic acids
PL318017A1 (en) Peptides
SI1043332T1 (sl) Dipeptidi, ki obsegajo ciklopentan-beta-aminokisline
HU9502018D0 (en) Synthetic peptide derivatives and the salts thereof
IL115317A0 (en) Proteins
GB9425380D0 (en) Peptides
GB9519865D0 (en) Protein
SI0696577T1 (en) Synthetic excitatory amino acids
ZA956773B (en) Synthetic excitatory amino acids.
ZA965800B (en) Novel quinoxaline- and quinoxalinylalkane-phosphonic acids
GB9622436D0 (en) Protein
GB9605434D0 (en) Excitatory amino acid derivatives
IE901264L (en) Mercapto-acyl amino acids
IL108591A0 (en) Amino acid sequence determination
IL114751A0 (en) Amino acid sequence determination
GB9411049D0 (en) Peptide
GB9420989D0 (en) Protein
GB9511729D0 (en) Protein
GB9522660D0 (en) Protein
GB9501486D0 (en) Protein

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050811